text: Post acute sequelae of COVID 19 in a non hospitalized cohort Results from the Arizona CoVHORT Clinical presentation outcomes and duration of COVID 19 has ranged dramatically While some individuals recover quickly others suffer from persistent symptoms collectively known as long COVID or post acute sequelae of SARS CoV 2 PASC Most PASC research has focused on hospitalized COVID 19 patients with moderate to severe disease We used data from a diverse population based cohort of Arizonans to estimate prevalence of PASC defined as experiencing at least one symptom 30 days or longer and prevalence of individual symptoms There were 303 non hospitalized individuals with a positive lab confirmed COVID 19 test who were followed for a median of 61 days range 30 250 COVID 19 positive participants were mostly female 70 non Hispanic white 68 and on average 44 years old Prevalence of PASC at 30 days post infection was 68 7 95 confidence interval 63 4 73 9 The most common symptoms were fatigue 37 5 shortness of breath 37 5 brain fog 30 8 and stress anxiety 30 8 The median number of symptoms was 3 range 1 20 Amongst 157 participants with longer follow up 60 days PASC prevalence was 77 1 